Industry Insights Logo

Unlocking Greater 340B Savings

SPONSORED CONTENT

The 340B program serves as a lifeline for many communities, allowing them to provide critical services to vulnerable, underserved patients. But unfortunately, the industry faces a spectrum of challenges, from mounting drug manufacturer restrictions to incomplete referral claims capture, which hinder

Read More »
Industry Insights Logo

340B Outlook from Capitol Hill, Federal Courts, and the States

SPONSORED CONTENT

Get the latest developments in the 340B program with some of the most respected experts in the field. Verity Solutions will be hosting this lively panel discussion again where you will get an up-to-the-minute

Read More »
Industry Insights Logo

Unlocking the TRUE POTENTIAL of 340B

SPONSORED CONTENT

Primary care organizations often view themselves as a “Medical Home” for their patients, focusing on resolving patient health problems through their medical services. However, a significant challenge for providers lies in the inability to monitor and influence a patient’s behavior in the time

Read More »
Industry Insights Logo

3 Things Hospitals and Grantees Need to Know about the Genesis Decision

SPONSORED CONTENT

The much-awaited decision in the Genesis Health Care patient definition case in federal district court in South Carolina provides 340B hospitals and federal grantees welcome re-affirmations of the importance of the vital safety-net care they provide as well as Congress’s intent to

Read More »
Industry Insights Logo

Upcoming DIR Fee Changes and Their Potential Impact on 340B Programs

SPONSORED CONTENT

The Centers for Medicare & Medicaid Services (CMS) has issued a final rule that goes into effect on January 1, 2024 that changes the way Direct and Indirect Remuneration (DIR) fees are collected. To understand the impact

Read More »
Industry Insights Logo

340B…or not to B…?

Robin George headshot

SPONSORED CONTENT

The 340B program, enacted in 1992, enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.

In 2010, the 340B program was expanded under the Affordable Care Act, allowing covered entities to contract with an unlimited number

Read More »
Industry Insights Logo

4 Ways Hospital Pharmacies Can Unlock Financial Stability

SPONSORED CONTENT

With so many challenges facing health systems today — from 340B contract pharmacy restrictions to drug shortages, labor issues, and ever-rising costs — revenue integrity has become essential to financial stability.

With huge increases in drug expenditures from pre-pandemic levels, health systems must

Read More »
Industry Insights Logo

5 Best Practices for Running and Optimizing a Mixed-Use Program

SPONSORED CONTENT

To ensure compliance, maximize savings, and streamline operations, consider these five best practices.

1. Proficiency in Data Management

To effectively manage your 340B program, it’s crucial to comprehend how data is created, stored, and transmitted to your Third-Party Administrator (TPA). Typically,

Read More »
Industry Insights Logo

10 Questions to Ask Your 340B TPA about Your Contract and Fees

Holly Russo, Maxor 340B

SPONSORED CONTENT

If you have one or more agreements with 340B Third Party Administrator(s) (TPA) to manage your contract pharmacy arrangements, how much do you know about those contracts and associated fees?  Chances are, you don’t know the answers to all the questions that follow.  Be

Read More »
Industry Insights Logo

The 340B Program’s Current State of Play

SPONSORED CONTENT

Despite calls for reform by opponents, 340B enjoys broad bipartisan support.  On the legislative front, lawmakers have introduced multiple bills in the House and Senate that, if enacted, would alter program operations.  Multiple court cases regarding contract pharmacy use are working their way through the judicial

Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live